Integra LifeSciences (NSDQ:IART) shares ticked up in pre-market trading today after the medical device company reported third-quarter numbers that topped estimates. Plainsboro, N.J.-based Integra posted losses of -27.6 million, or -32¢ per share, on sales of $379.1 million for the three months ended Sept. 30, marking a swing to red ink on sales growth of […]
Varian gets a jolt from meet-and-beat fiscal numbers, 202 forecast
Varian Medical (NYSE:VAR) got a jolt today from its fiscal fourth-quarter and full-year results, which met the consensus earnings forecast and topped Wall Street’s expectations for sales, and added a pair of names to its senior leadership roster. Palo Alto, Calif.-based radiotherapy device maker posted profits of $89.3 million, or 97¢ per share, on sales of […]
Envista beats on earnings, misses on revenues with first quarterly report
Envista (NYSE:NVST), the Danaher (NYSE:DHR) dental spinout, today post third-quarter results that beat the consensus forecast on earnings but missed the revenues mark, in its first quarterly report since going public last month. Brea, Calif.-based Envista put up profits of $62.1 million, or 48¢ per share, on sales of $659.3 million for the three months ended Sept. […]
Baxter slumps on internal accounting probe
Share prices slumped today for Baxter (NYSE:BAX) after the healthcare giant revealed an internal probe into its foreign exchange trading practices dating back five years. The Chicago-area company said it’s tapped outside lawyers and consultants to assist with an investigation into intra-company trades designed to create foreign exchange gains or losses. “These transactions used a foreign […]
Opioid settlement deletes $3B in profits for Johnson & Johnson
Johnson & Johnson (NYSE:JNJ) today said a $4 billion settlement deal between its Janssen Pharmaceutical division and a group of state attorneys general over opioid drugs deleted some $3 billion from its bottom line. The New Brunswick, N.J.-based healthcare conglomerate last week posted third-quarter results that beat expectations, reporting profits of $4.83 billion ($1.81 per […]
3M slides on guidance cut despite Q3 earnings beat
Shares in 3M (NYSE:MMM) slid in pre-market trading today, despite third-quarter earnings that topped estimates, after the industrial conglomerate cut its outlook for the rest of the year. St. Paul, Minn.-based 3M posted profits of $1.58 billion, or $2.72 per share, on sales of $7.99 billion for the three months ended Sept. 30, amounting to a […]
Report: Agfa-Gevaert shops HIT unit
More than two years after announcing plans to spin out its HIT division, Belgian graphics giant Agfa-Gevaert (EBR:AGFB) is reportedly putting the business on the auction block. In August 2017 the Brussels-based company began planning the establishment of the HIT division as a stand-alone business within Agfa-Gevaert. Yesterday the company began accepting bids in an auction […]
Mexico sues Stryker over alleged bribery scheme
Mexico’s federal health agency last week sued Stryker (NYSE:SYK) over an alleged bribery scheme, accusing the company of bribing officials at the Instituto Mexicano del Seguro Social to reap more than $2 million in illicit profits. The lawsuit, filed Oct. 18 in the U.S. District Court for Western Michigan, claims that Kalamazoo, Mich.-based Stryker induced […]
Boston Scientific tops Q3 estimates, raises outlook
Boston Scientific (NYSE:BSX) beat the consensus estimate for both sales and earnings with its third-quarter results and raised its outlook on the rest of the year, sending share prices up today in pre-market trading. The Marlborough, Mass.-based medical device company posted profits of $126.0 million, or 9¢ per share, on sales of $2.71 billion for the […]
Nico wins FDA nod for Myriad Novus resection tool
Nico Corp. said it won 501(k) clearance from the FDA for its Myriad Novus resection tool. Indianapolis-based Nico said the device combines its Myriad resection tool with a xenon light and tissue-harvesting capabilities during intracerebral hemorrhage clot removal and subcortical tumor resection. “The Novus represents the next generation of Nico’s flagship product the Myriad,” president […]
Verix Health lands $8m Series A for steerable devices
Verix Health said today that it closed a Series A round worth $8 million for the steerable devices it’s developing. Santa Clara, Calif.-based Verix said Ajax Health led the round, which included Aperture Venture Partners and Western Technology Investment. The funds are earmarked for R&D and preparations for commercialization for the steerable devices, which are […]
